CHNA
Loncar China BioPharma ETF
CHNA
CHNA
Delisted
CHNA was delisted on the 20th of October, 2023.
4 hedge funds and large institutions have $1.74M invested in Loncar China BioPharma ETF in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$654K |
| 2 |
BBPWM
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
|
+$12K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.73K |
Top Sellers
| 1 |
FEM
Fulcrum Equity Management
Plano,
Texas
|
-$340K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$31K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $1.64M | +$654K | +24,430 | +66% |
|
2
Morgan Stanley
New York
| $59K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $29K | +$3.73K | +141 | +15% |
|
|
BBPWM
4
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| $12K | +$12K | +449 | New |
|
|
FEM
5
Fulcrum Equity Management
Plano,
Texas
| – | -$340K | -9,126 | Closed |
|
|
6
Osaic Holdings
Scottsdale,
Arizona
| – | -$31K | -830 | Closed |
|